AICDA and chronic myelogenous leukemia, BCR-ABL1 positive: Historically IFN-alpha has been used in MPN, including chronic myeloid leukemia (CML), systemic mast cell disease, and hypereosinophilic syndrome, and has been associated with the occurrence of several AID and AIC.